Skip to content Skip to footer
Autoimmune diseases

Pipeline

Our fields of research

Remyelinating agents

GPCR modulating agents of the GI tract

FTX 101
Demyelinating diseases

Undisclosed target
GI diseases

Undisclosed target Eosinophilic Esophagitis

Discovery

Candidate

IND-enabling

Clinical

FTX 101 – Demyelinating diseases
IND-enabling
Undisclosed target – GI diseases
Discovery
Undisclosed target – Eosinophilic Esophagitis
Discovery

Find out more about
our science

7171 Frederick-Banting
Saint-Laurent, Québec 
H4S 1Z9,  Canada

Finding hope by expanding the frontiers of therapy

Find Therapeutics © 2022. All Rights Reserved.